(0.89%) 5 127.25 points
(0.20%) 38 365 points
(1.21%) 17 779 points
(0.57%) $84.05
(-2.63%) $1.595
(0.34%) $2 350.50
(0.98%) $27.62
(1.41%) $933.50
(-0.02%) $0.932
(-0.08%) $10.94
(-0.01%) $0.799
(-0.02%) $92.15
Live Chart Being Loaded With Signals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain...
Stats | |
---|---|
Today's Volume | 240 995 |
Average Volume | 138 824 |
Market Cap | 14.58M |
EPS | $0 ( 2024-04-04 ) |
Next earnings date | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.313 |
ATR14 | $0.0740 (8.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-15 | Nantahala Capital Management, Llc | Buy | 0 | Common Stock |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 2 205 883 | 2023 Series A Warrants |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 2 205 883 | 2023 Series B Warrants |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 750 883 | 2023 Pre-Funded Warrants |
2024-03-15 | Nantahala Capital Management, Llc | Buy | 755 000 | Call Option (Right to Buy) |
INSIDER POWER |
---|
83.06 |
Last 92 transactions |
Buy: 3 436 001 | Sell: 171 828 |
Volume Correlation
AcelRx Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
NAKD | 0.974 |
TNGX | 0.964 |
UTHR | 0.952 |
IMV | 0.941 |
WTBA | 0.94 |
AVIR | 0.939 |
UK | 0.937 |
APM | 0.936 |
BFRI | 0.935 |
GRNA | 0.934 |
10 Most Negative Correlations | |
---|---|
PDFS | -0.956 |
IDCC | -0.956 |
ALTR | -0.956 |
ANSS | -0.954 |
LPTH | -0.953 |
INTA | -0.952 |
SLMBP | -0.952 |
APXI | -0.952 |
SJ | -0.952 |
NCAC | -0.951 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AcelRx Pharmaceuticals Correlation - Currency/Commodity
AcelRx Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $651 000 |
Gross Profit: | $651 000 (100.00 %) |
EPS: | $-0.000700 |
Q3 | 2023 |
Revenue: | $117 000 |
Gross Profit: | $117 000 (100.00 %) |
EPS: | $-0.0810 |
Q2 | 2023 |
Revenue: | $253 000 |
Gross Profit: | $-1.30M (-513.44 %) |
EPS: | $-0.400 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.05M (0.00 %) |
EPS: | $0.490 |
Financial Reports:
No articles found.
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators